These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1113 related articles for article (PubMed ID: 16595494)

  • 1. Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization.
    Choi JY; Lee KS; Kim HJ; Shim YM; Kwon OJ; Park K; Baek CH; Chung JH; Lee KH; Kim BT
    J Nucl Med; 2006 Apr; 47(4):609-15. PubMed ID: 16595494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of dual-phase 18F-FDG PET in characterizing thyroid incidentalomas.
    Hsiao YC; Wu PS; Chiu NT; Yao WJ; Lee BF; Peng SL
    Clin Radiol; 2011 Dec; 66(12):1197-202. PubMed ID: 21907336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma.
    Kim TY; Kim WB; Ryu JS; Gong G; Hong SJ; Shong YK
    Laryngoscope; 2005 Jun; 115(6):1074-8. PubMed ID: 15933524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients.
    Barrio M; Czernin J; Yeh MW; Palma Diaz MF; Gupta P; Allen-Auerbach M; Schiepers C; Herrmann K
    Nucl Med Commun; 2016 Dec; 37(12):1290-1296. PubMed ID: 27612034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of solitary thyroid nodule on 18F-FDG PET/CT and high-resolution ultrasonography.
    D'Souza MM; Marwaha RK; Sharma R; Jaimini A; Thomas S; Singh D; Jain M; Bhalla PJ; Tripathi M; Tiwari A; Mishra A; Mondal A; Tripathi RP
    Ann Nucl Med; 2010 Jun; 24(5):345-55. PubMed ID: 20373060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid incidentaloma identified by ¹⁸F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance.
    Pagano L; Samà MT; Morani F; Prodam F; Rudoni M; Boldorini R; Valente G; Marzullo P; Baldelli R; Appetecchia M; Isidoro C; Aimaretti G
    Clin Endocrinol (Oxf); 2011 Oct; 75(4):528-34. PubMed ID: 21575027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal uptake of fluorodeoxyglucose by the thyroid in patients undergoing initial disease staging with combined PET/CT for non-small cell lung cancer.
    Yi JG; Marom EM; Munden RF; Truong MT; Macapinlac HA; Gladish GW; Sabloff BS; Podoloff DA
    Radiology; 2005 Jul; 236(1):271-5. PubMed ID: 15987980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can the pathology of a thyroid nodule be determined by positron emission tomography uptake?
    Boeckmann J; Bartel T; Siegel E; Bodenner D; Stack BC
    Otolaryngol Head Neck Surg; 2012 Jun; 146(6):906-12. PubMed ID: 22307576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of thyroid FDG uptake incidentally identified on FDG-PET/CT imaging.
    Chen W; Parsons M; Torigian DA; Zhuang H; Alavi A
    Nucl Med Commun; 2009 Mar; 30(3):240-4. PubMed ID: 19262287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of 18F-FDG PET/CT uptake patterns in Waldeyer's ring for differentiating benign from malignant lesions in lateral pharyngeal recess of nasopharynx.
    Chen YK; Su CT; Chi KH; Cheng RH; Wang SC; Hsu CH
    J Nucl Med; 2007 Jan; 48(1):8-14. PubMed ID: 17204693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal uptake of (18)F-fluorodeoxyglucose by thyroid in patients with nonthyroidal head and neck cancers.
    Nam SY; Roh JL; Kim JS; Lee JH; Choi SH; Kim SY
    Clin Endocrinol (Oxf); 2007 Jul; 67(1):135-9. PubMed ID: 17465995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence and clinical significance of (18) F-2-fluoro-2-deoxy-D-glucose (FDG) uptake in the thyroid gland on PET or PET-CT in patients with lymphoma.
    Lin M; Wong C; Lin P; Shon IH; Cuganesan R; Som S
    Hematol Oncol; 2011 Jun; 29(2):67-74. PubMed ID: 20635328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidental thyroid uptake on F-18 FDG PET/CT: correlation with ultrasonography and pathology.
    Kang BJ; O JH; Baik JH; Jung SL; Park YH; Chung SK
    Ann Nucl Med; 2009 Oct; 23(8):729-37. PubMed ID: 19768518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid incidentalomas identified by 18F-FDG PET: sonographic correlation.
    Kwak JY; Kim EK; Yun M; Cho A; Kim MJ; Son EJ; Oh KK
    AJR Am J Roentgenol; 2008 Aug; 191(2):598-603. PubMed ID: 18647938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid incidentalomas detected on 18F-fluorodeoxyglucose-positron emission tomography/computed tomography: Thyroid Imaging Reporting and Data System (TIRADS) in the diagnosis and management of patients.
    Yoon JH; Cho A; Lee HS; Kim EK; Moon HJ; Kwak JY
    Surgery; 2015 Nov; 158(5):1314-22. PubMed ID: 25958065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of 18F-fluorodeoxyglucose positron emission tomography in preoperative assessment of cytologically indeterminate thyroid nodules.
    Sebastianes FM; Cerci JJ; Zanoni PH; Soares J; Chibana LK; Tomimori EK; de Camargo RY; Izaki M; Giorgi MC; Eluf-Neto J; Meneghetti JC; Pereira MA
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4485-8. PubMed ID: 17684046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of thyroid incidentalomas identified by 18F-FDG PET/CT: correlation of ultrasonograpy findings with cytology results.
    Demir Ö; Köse N; Özkan E; Ünlütürk U; Aras G; Erdoğan MF
    Nucl Med Commun; 2016 Jul; 37(7):715-20. PubMed ID: 26963467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.
    Okada M; Shimono T; Komeya Y; Ando R; Kagawa Y; Katsube T; Kuwabara M; Yagyu Y; Kumano S; Imaoka I; Tsuchiya N; Ashikaga R; Hosono M; Murakami T
    Ann Nucl Med; 2009 Jun; 23(4):349-54. PubMed ID: 19340526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of incidental focal hypermetabolic uptake in the breast as detected by 18F-FDG PET/CT: clinical significance and differential diagnosis.
    Chae EY; Cha JH; Kim HH; Shin HJ; Kim HJ; Oh HY; Koh YH; Moon DH
    Acta Radiol; 2012 Jun; 53(5):530-5. PubMed ID: 22593124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects.
    Kang KW; Kim SK; Kang HS; Lee ES; Sim JS; Lee IG; Jeong SY; Kim SW
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4100-4. PubMed ID: 12970270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.